Search clinical trials for: Hypofractionated Stereotactic Radiotherapy

Total 3897 results

Huashan Hospital

Active, not recruiting

Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

Malignant Glioma

China
University Health Network, Toronto
Princess Margaret Hospital, Canada

Terminated

Perfexion Brain Metastasis (HF-SRT)

Brain Metastases

Canada
Chang Gung Memorial Hospital

Recruiting

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT (HF-SRT)

Brain Metastases, Adult

Taiwan
Barretos Cancer Hospital

Withdrawn

Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis

Cancer | Metastasis

Brazil
National Taiwan University Hospital

Unknown

A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic Lymphadenopathy

Metastasis of Malignant Neoplasm to Lymph Node

Taiwan
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital

Recruiting

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer | Brain Metastases | Stage IV Non-small Cell Lung Cancer

China
Centre Jean Perrin
GORTEC

Active, not recruiting

STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 (STEREOPOSTOP)

Head and Neck Neoplasms

France
Technical University of Munich

Recruiting

Hypofractionated Versus Single Fraction Stereotactic Adjuvant Radiotherapy to the Resection Cavity of Brain Metastases (SATURNUS)

Brain Metastases | Resection Cavity

Germany
Barretos Cancer Hospital

Withdrawn

Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases

Brain Metastases

Brazil
Susanne Rogers
University of Basel; Technical University of Munich

Recruiting

Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases (PREOP-2)

Brain Metastases, Adult

Switzerland
Hospices Civils de Lyon

Completed

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid (RPAH2)

Prostatic Adenocarcinoma

France
Centre Francois Baclesse
Association de Neuro-Oncologues d'Expression Francaise

Active, not recruiting

Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation. (OligoBM-01)

Brain Metastasis | Oligoprogression

France
NRG Oncology
National Cancer Institute (NCI)

Active, not recruiting

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Liver | Metastatic Breast Carcinoma | Metastatic Malignant Neoplasm in the Lung and other conditions

United States, Canada, Saudi Arabia, Korea, Republic of
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Stereotactic Radiosurgery Compared to Observation in Treating Patients With Brain Metastases

Metastatic Malignant Neoplasm in the Brain

United States
Hospital San Carlos, Madrid
Asociación de Afectados Por Tumores Cerebrales en España (ASATE)

Recruiting

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma (GLINERA)

Glioblastoma | Glioblastoma Multiforme | Radiotherapy; Complications | Glioblastoma, IDH-wildtype | Cancer Brain

Spain
Andre Tsin Chih Chen

Active, not recruiting

Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme (GBM Hypo RT)

Recurrent Glioblastoma Multiforme

Brazil
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Lung Small Cell Carcinoma

United States
NRG Oncology
National Cancer Institute (NCI)

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast Carcinoma

United States, Canada, Switzerland
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Completed

Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Advanced Adult Hepatocellular Carcinoma | Localized Non-Resectable Adult Liver Carcinoma | Recurrent Adult Liver Carcinoma | Adult Hepatocellular Carcinoma

United States
Stanford University

Completed

Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform (Tx-Treatment)

Glioblastoma | Glioblastoma Multiforme | Cancer of Brain and Nervous System

United States
Maria Sklodowska-Curie National Research Institute...

Recruiting

Radiotherapy With Hyperthermia in Recurrent and Radiation-Induced Sarcomas (HOT)

Recurrent Soft Tissue Sarcoma | Recurrent Sarcoma | Radiation Induced Neoplasms | Radiation-Induced Cancer

Poland
Alexander Chi

Not yet recruiting

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage II

China
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Preop fSRS for Resectable Brain Metastases

Brain Metastases | Brain Lesion

United States
Hospital da Baleia

Unknown

Hypofractionated Versus Conventional Fractionation Radiotherapy

Breast Cancer | Radiation Toxicity
University of Utah
National Cancer Institute (NCI)

Recruiting

Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer (RT-PACE)

Cervical Carcinoma | Endometrial Carcinoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases

Metastatic Malignant Neoplasm in the Brain | Metastatic Malignant Neoplasm

United States
University Hospital Heidelberg

Recruiting

Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies (PAROS)

Prostate Cancer

Germany
University of Utah

Active, not recruiting

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (SOAR)

Prostate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Recurrent Prostate Carcinoma | Oligometastasis | PSA Failure

United States
Tampere University Hospital

Completed

Prostate Cancer Stereotactic Radiotherapy (ESKO)

Prostate Neoplasms | Toxicity Due to Radiotherapy

Finland
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases

Malignant Neoplasm | Metastatic Malignant Neoplasm in the Brain

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

Metastatic Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Pathologic Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Malignant Neoplasm in the Brain

United States
University of Utah

Active, not recruiting

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer (NOVEMBER)

Stage 0 Breast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma In Situ

United States
Jonsson Comprehensive Cancer Center
MiraDX

Active, not recruiting

Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial (GARUDA)

Prostate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Hypofractionated Post Mastectomy Radiation With Two-Stage Expander/Implant Reconstruction

Breast Carcinoma

China
Medical University of Graz

Terminated

Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

Prostate Cancer | Radiotherapy Side Effect

Austria
Sunnybrook Health Sciences Centre
Canadian Association of Radiation Oncology

Completed

Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer (PHART6)

Prostate Cancer

Canada
Consorci Sanitari de Terrassa

Active, not recruiting

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Prostate Cancer | Faecal Incontinence

Spain
Postgraduate Institute of Medical Education and...

Completed

Late-term Effects of Hypofractionated Chest Wall and Regional Nodal Irradiation in Patients With Breast Cancer (LEHR)

Late Effects of Hypofractionated Radiotherapy in Breast Cancer
Alberta Health services

Completed

Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer

Prostate Cancer

Canada
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Prognostic Stage I Breast Cancer AJCC v8 | Prognostic Stage IA Breast Cancer AJCC v8 | Prognostic Stage IB Breast Cancer AJCC v8 | Prognostic Stage IIA Breast Cancer AJCC...

United States
North China Petroleum Bureau General Hospital

Recruiting

Moderate Hypofractionated Radiotherapy for Lung Cancer

Lung Cancer

China
University of Wisconsin, Madison

Active, not recruiting

Hypofractionated Radiotherapy for Soft Tissue Sarcomas

Soft Tissue Sarcoma

United States
University of Cincinnati
Children's Hospital Medical Center, Cincinnati

Completed

Hypofractionated Radiotherapy for Recurrent DIPG

Recurrent Diffuse Intrinsic Pontine Glioma

United States
Tata Medical Center

Completed

Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer (HYPORT)

Carcinoma Breast Stage IV

India
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain

United States
European Institute of Oncology

Active, not recruiting

Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion

Adenocarcinoma of Prostate

Italy
Danish Breast Cancer Cooperative Group
Danish Cancer Society

Active, not recruiting

Hypofractionated Versus Standard Fractionated Whole Breast Irradiation to Node-negative Breast Cancer Patients

Breast Cancer | Carcinoma in Situ of the Breast

Denmark
Ahmed Ahm

Unknown

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Breast Cancer

Egypt
University of Rochester

Completed

Study for Using Radiosurgery on Limited Metastases of Breast Cancer

Breast Cancer, Metastatic

United States
Jonsson Comprehensive Cancer Center

Withdrawn

Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases

Brain Tumor | Malignant Neoplasm, Brain

United States

Search clinical trials for: Hypofractionated Stereotactic Radiotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations